Cancer Biotech MultiVir Pulls Plug On IPO Plans
Cancer gene therapy developer MultiVir Inc., which is backed by Pope Investments LLC, withdrew its initial public offering plans on Thursday, officially calling off efforts to tap the public market for...To view the full article, register now.
Already a subscriber? Click here to view full article